This inventor holds 21 USPTO granted patents and 2 published patent applications and 3 EPO patents, primarily in Antibacterial Compounds. Top assignees: Isis Pharmaceuticals, Inc., Abbott Laboratories Corporation, Farmitalia Carlo Erba. Active years: 1978-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Beaconsfield, CA (1978 - 2021)
- Irvine, CA (US) (2018 - 2022)
Company Filing History:
6 out of 1,035 
5 out of 4,190 
3 out of 208 
Years Active: 1978-2022
Areas of Expertise:
Title: **Innovations by Stephen Hanessian: Pioneering Small Molecule Therapeutics**
Introduction
Stephen Hanessian is a distinguished inventor based in Beaconsfield, CA, with a remarkable portfolio of 21 patents to his name. His innovative contributions primarily focus on synthetic sphingolipid-like molecules, which play a crucial role in the treatment of various diseases, including neoplasms and cancers. His work exemplifies the intersection of chemistry and medicine, leading to significant advancements in therapeutic formulations.
Latest Patents
Among his latest patents, Hanessian has developed synthetic sphingolipid-like molecules and outlined methods for their synthesis and application in drug formulations. His inventions include small molecules comprised of azacyclic constrained sphingolipid-like compounds. These inventions propose effective treatments through formulations directed at combating diseases such as neoplasms and other cancers. The therapeutics he has developed consist of a therapeutically effective dose of one or more small molecule compounds, available as pharmaceutically effective salts or in pure form. They are designed for various administration routes, including oral, intravenous, or intramuscular methods.
Career Highlights
Hanessian's career is marked by impactful roles at prominent organizations, including Isis Pharmaceuticals, Inc. and Abbott Laboratories Corporation. His extensive experience in drug development has fostered innovations that contribute significantly to biomedical research and therapeutic solutions. His work has positioned him as a key figure in the realm of synthetic compounds aimed at treating critical health conditions.
Collaborations
Throughout his career, Stephen Hanessian has collaborated with notable colleagues, including Eric E. Swayze and Janek Szychowski. These partnerships have facilitated the synergistic exchange of ideas and knowledge, enhancing the scope and success of their mutual projects in drug discovery and development.
Conclusion
Stephen Hanessian's innovative spirit and dedication to advancing medical science through small molecule therapeutics are evident in his extensive patent portfolio. His contributions continue to influence the field of drug development, paving the way for future innovations in treating diseases like cancer. With a robust career and valuable collaborations, Hanessian exemplifies the profound impact an inventor can have on healthcare advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile